Similarly, the expression of CD68 and CD45 increased after the TAA intervention, with the Lrrk2−/−-HE mice reporting the highest CD68, followed by the Lrrk2G2019S-HE mice, and then the WT-HE mice (p < 0.05) (Fig. 5A–C). This evidence concerns the gene CD68 and hereditary elliptocytosis.